Clinical trial
Modulation of Ghrelin Release by Exercise Intensity: The Role of Obesity and Prediabetes Status
NCT04581980 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Ghrelin Release by Exercise Intensity: The Role of Obesity and Prediabetes Status
- Lead sponsor
- University of Virginia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 14, 2020
- Completion date
- April 16, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular risk factor, insulin resistance, obesity